(NASDAQ:CHEK), Check-Cap Ltd. Issues Strong Condemnation of MediPharm Labs Chairman Chris Taves for Fabricated Defamatory Statements Press Releases Taves Times his Attack to Commence 23 Minutes before the Start of Shabbat to Delay the Company from Responding ISFIYA, ISRAEL, June 04, 2025 (GLOBE NEWSWIRE) — Check-Cap Ltd. (NASDAQ: CHEK) (“Check-Cap” or the “Company”), a clinical-stage […]
(NASDAQ:VIGL), WATERTOWN, Mass., June 04, 2025 (GLOBE NEWSWIRE) — Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases, today announced an update on the Phase 2 IGNITE open-label clinical trial evaluating iluzanebart, a monoclonal antibody TREM2 agonist, for the potential treatment of
(NASDAQ:NCEW), Hong Kong, China, June 04, 2025 (GLOBE NEWSWIRE) — On June 4, 2025, New Century Logistics (BVI) Limited (hereinafter referred to as “New Century”) has entered into a Letter of Intent (hereinafter referred to as “LOI”) with Ms. Chiu Nga Ting, the sole shareholder of Asiatic Logistics Limited ( hereinafter referred to as “Asiatic”),
(NASDAQ:PPBT),(TASE:PPBT.TA), REHOVOT, Israel, June 04, 2025 (GLOBE NEWSWIRE) — Purple Biotech Ltd. (“Purple Biotech” or “the Company”) (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance, today announced a poster presentation on its novel CAPTN-3 tri-specific antibody platform, will be featured at the Annual Congress of
(CNSX:IDK),(OTC US:IDKFF),(Other OTC:IDKFF),(CNSX:IDK.CN),(CNSX:AIML),(CNSX:AIML.CN), TORONTO, June 04, 2025 (GLOBE NEWSWIRE) — ThreeD Capital Inc. (“ThreeD” or the “Company”) (CSE:IDK) (OTCQX:IDKFF), a Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, congratulates AI/ML Innovations Inc. (CSE: AIML) (“AIML”), on signing a Letter of Intent (“LOI”) between its wholly
(NASDAQ:DSGN), Initial Data from the Ongoing, Blinded Phase 1 Single-Ascending Dose Trial Has Demonstrated Favorable Safety and Pharmacokinetics IND Application Submitted to Expand RESTORE-FA Trial to U.S. Sites; Notice Received from FDA Placing Clinical Hold on IND Application to Open U.S. Sites CARLSBAD, Calif., June 04, 2025 (GLOBE NEWSWIRE) — Design Therapeutics, Inc. (Nasdaq: DSGN),
(NASDAQ:NYAX),(TASE:NYAX),(TASE:NYAX.TA), HERZLIYA, Israel, June 04, 2025 (GLOBE NEWSWIRE) — Nayax Ltd. (Nasdaq: NYAX; TASE: NYAX), a global commerce enablement and payments platform designed to help merchants scale their business by simplifying payments and maximizing loyalty, today announced a strategic partnership to provide comprehensive payment solutions for Lynkwell, a leading energy infrastructure provider managing thousands of
(NASDAQ:STSS),(NASDAQ:STSSW), Shipments include initial deliveries of SecureGard(TM) and SoloGard(TM) smart safety syringes from its Hungary-based manufacturing facility Deliveries mark the Company's transition to a commercial-stage, revenue-generating company NEW YORK, June 04, 2025 (GLOBE NEWSWIRE) — Sharps Technology, Inc. (Nasdaq: “STSS” and “STSSW”) (“Sharps”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class smart-safety
(NASDAQ:UPB), WALTHAM, Mass., June 04, 2025 (GLOBE NEWSWIRE) — Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders, today announced that Rand Sutherland, MD, Chief Executive Officer of Upstream Bio, will participate in a fireside chat at the Goldman Sachs 46th Annual Global
(TSX:ISC), REGINA, Saskatchewan, June 04, 2025 (GLOBE NEWSWIRE) — Information Services Corporation (TSX:ISC) (“ISC” or the “Company”) today announced that it has authorized, and the Toronto Stock Exchange (the “TSX”) has accepted a notice filed by ISC of its intention to make a normal course issuer bid (the “NCIB”), to purchase for cancellation up to